Is PRGO or PRLD more undervalued in 2026?

CirclFi compares Perrigo Company plc (PRGO) and Prelude Therapeutics Incorporat (PRLD) using 13 institutional-grade valuation models. PRGO has a Quality of Company score of 5.9/10 while PRLD scores 5.9/10.

Which is a better buy — PRGO or PRLD?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do PRGO and PRLD valuations compare?

PRGO at $11.05 and PRLD at $3.92 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

PRGO vs PRLD Valuation Comparison 2026 — Intrinsic Value Analysis

PRGO

Pharmaceutical Preparations

Perrigo Company plc

Quality

5.9

out of 10

Value Trap

LOW

Price

$11.05

Last close

Models

11/13

Active

PRLD

Pharmaceutical Preparations

Prelude Therapeutics Incorporat

Quality

5.9

out of 10

Value Trap

SAFE

Price

$3.92

Last close

Models

9/13

Active

Model-by-Model Comparison

Model	Type	PRGO Fair Value	PRGO Upside	PRLD Fair Value	PRLD Upside
Bayesian DCF	Intrinsic	$2.94	-73.7%	$1.25	-68.2%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$14.77	+33.7%	—	—
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	—	—	$1.75	-55.4%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for PRGO vs PRLD — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

PRGO vs PRLD — Which Stock Is More Undervalued?

PRGO scores higher with a 5.9/10 quality rating vs PRLD's 5.9/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Perrigo Company plc (PRGO) and Prelude Therapeutics Incorporat (PRLD) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

PRGO currently trades at $11.05 with a QOC of 5.9/10, while PRLD trades at $3.92 with a QOC of 5.9/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).